Professional Documents
Culture Documents
JOINT PAIN
Inflammatory
OSTEOARTHRITIS
Diagnosis knee OA
clinical
Age > 50 ys Stiffness < 30 mts Crepitus Bony pain Bony swelling Palp: No warm ESR < 40 mm/hrs Sinovial Fluid OA: 5 of the 9 above
Age > 50 yrs Stiffness < 30 mts Crepitus Bony pain Bony swelling Palp: no warm OA: 3 of the 6 above
American College of Rheumatology (ACR 1986) Adopt: IRA 2004, panduan Diagnosis & Pengelolaan OA
Grade 0 = normal Grade I = doubtful narrowing of joint space and possible osteophyte lipping Grade II = definite osteophyte and possible narrowing of the joint space Grade III = moderate multiple osteophytosis, definite narrowing of joint space, some sclerosis and possible deformity of bone contour. Grade IV = large osteophytes, markednarrowing of joint space, severe sclerosis and definite deformity of joint contour
Drugs in OA
Symptom
modifying drugs
Analgesics, NSAIDs
Corticosteroids Accupuncture?
Structure
modifying drugs
Spondyloarthropathies
A group of Inflammatory diseases Inheritance of human leukocyte antigen (HLA)-B27 increases the relative risk of developing spondyloarthropathy These diseases are not associated with rheumatoid factor and thus are often referred to as the "seronegative" spondyloarthropathies
Insidious Disease
Synovitis
(Asymmetrical or Predominantly lower limbs)
Alternate buttock pain Sacroiliitis Positive family history Psoriasis Inflammatory bowel disease Urethritis or cervicitis or acute diarrhea occurring within 1 month before the onset of arthritis
* European Spondyloarthropathy Study Group Criteria for Spondyloarthropathy, 1991 Dougados M, et al. Arthritis Rheum. 1991 Oct;34(10):1218-1227.
Spondyloarhtropathies (SpA)
Arthritis associated with acute anterior uveitis
Psoriatic Arthritis
Arthritis (Reiters)
SpA are a group of rheumatic disorders that share several common factors: 1. Synovitis and enthesitis 2. Similar association with HLA-B27 3. AS is the prototype
Arthritis of IBD
Granfors, Granfors, K. K. et et al. al. Arthritis Arthritis & & Rheum Rheum 2002, 2002, 46:606-13. 46:606-13. DougadosM. et al. Arthritis & Rheum 1991;34:1218-1227 DougadosM. et al. Arthritis & Rheum 1991;34:1218-1227 Munoz-Fernandez Best Pract Pract Res Res Clin Clin Rheumatol. Rheumatol. 2006 2006 Jun;20:487-505 Jun;20:487-505 Munoz-Fernandez and and Martin-Mola. Martin-Mola. Best
Peripheral Arthritis
Rheumatoid Arthritis
Polyarthritis ( joint)
Spondyloarthropathy
Arthritis ( Oligoarthritis) Arthritis 4
Eye
Uveitis
Peripheral disease
Skin
Psoriasis
Gut
Inflammatory bowel disease (IBD)
De Quervain Tendinitis
Trigger finger
Entesitis
Achiles Tendinitis
Tendinitis dorsum
Plantar fasciitis
15
Hallmark of AS is fusion of the spine & sacroiliac joints because of development of first cartilage and then bone bridging the joints.
Bamboo Spine
Special maneuvers:
Clinical criteria
Low back pain and stiffness for >3 mo, which improves
with exercise, but is not relieved by rest Limited lumbar spine motion: in sagittal and frontal planes Limitations of chest expansion (age/sex standardized)
Definite AS = 1 clinical plus 1 radiographic criteria Probable AS = 3 clinical criteria and no radiologic criteria or 1 radiologic criterion and no clinical criteria
van der Linden S, et al. Arthritis Rheum. 1984;27:361-368.
Contrasted to RA
SpA
Mostly MALE Negative RF Primary involvement
RA
Mostly FEMALE Typically RF positive Primary involvement
Treatment
Medication
NSAID DMARDS ( mtx,
Non pharmacologic
Physical therapy Exercise Surgical intervention Corrective surgery Decompression surgery Peripheral joint
arthroplasty
Rheumatoid Arthritis
Description
Morning stiffness Arthritis of 3 or more joints Arthritis of hand joints Symmetric arthritis Rheumatoid nodules Serum rheumatoid factor Radiographic changes
A person shall be said to have rheumatoid arthritis if he or she has satisfied 4 of 7 criteria, with criteria 14 present for at least 6 weeks
Rheumatoid Arthritis
Deformities
Boutenaire deformities
Rheumatoid Arthritis
Extraarticular Involvement
Pulmonary Pleurasy
Biologics
Etanercept (Enbrel) Infliximab (Remicade) Adalimumab (Humira) Golimumab (Simponi) Certolizumab Pegol (Cimzia) Anakinra (Kineret) Rituximab (Rituxan) Abatacept (Orencia) Tocilizumab (Actemra)
THANK YOU